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Objectives. The purpose of this study was to evaluate a new
technique for sterilizing nonlumen electrophysiology catheters
that uses hydrogen peroxide gas plasma.
Background. The reuse of electrophysiology catheters may
potentially result in a significant cost savings. While ethylene
oxide sterilization appears to be safe and effective from a clinical
standpoint, toxic ethylene oxide residuals, which exceed Food and
Drug Administration standards, have been reported.
Methods. Ten nonlumen electrophysiology catheters were ex-
tensively evaluated. Each catheter was used five times and re-
sterilized after each use with hydrogen peroxide gas plasma. Tests
for sterility, mechanical and electrical integrity, chemical residu-
als and standard and electron microscopic inspection were per-
formed.
Results. Loss of electrical integrity or mechanical integrity was
not observed in any catheter. No evidence of microbial contami-
nation was found. Surface integrity was preserved except for one
ablation catheter that exhibited fraying of the insulation at the
insulation-electrode interface. Surface inspection using standard
magnification and electron microscopy revealed no significant
change in surface characteristics associated with the sterilization
process. Hydrogen peroxide was the only chemical residual noted,
with an average concentration of 0.22% by weight, which is within
accepted American Association for the Advancement of Medical
Instrumentation limits. The cost for a standard electrophysiology
catheter ranges from $200 to $800, and one sterilization cycle
costs $10. If electrophysiology catheters are used five times,
resterilization could potentially result in a savings of $2,000 per
catheter, or $9,000 for five ablation procedures.
Conclusions. Hydrogen peroxide gas plasma sterilization may
provide a cost-effective means of sterilizing nonlumen electrophys-
iology catheters without the problem of potentially harmful chem-
ical residuals. However, careful visual inspection of catheters,
particularly at the insulation–electrode interface, is required if
catheter reuse is performed.
(J Am Coll Cardiol 1998;32:1384–8)
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Radiofrequency catheter ablation has emerged as an impor-
tant and therapeutic option for patients suffering from a
variety of arrhythmias (1–5). While extremely effective, radio-
frequency catheter ablation is an invasive procedure that costs
$5,000 to $16,000 (6–8). A significant portion of the cost of an
ablation procedure is the cost of the multielectrode diagnostic
and ablation electrophysiology catheters. Several studies have
addressed the issue of repeated use of electrophysiology
catheters using ethylene oxide gas as the sterilizing agent
(9–11). While catheter reuse appears to be safe and effective
from a clinical standpoint and can lead to a significant cost
savings, the quantity of ethylene oxide residuals after steriliza-
tion exceeds Food and Drug Administration (FDA) standards
(11). In addition, the potentially toxic levels of ethylene oxide
remained even after 48 h of aeration (11).
A recently introduced sterilization technique that uses
hydrogen peroxide gas plasma as the sterilizing agent has been
approved by the FDA. We prospectively evaluated the safety
and efficacy of hydrogen peroxide plasma sterilization for
nonlumen electrophysiology catheters.
Methods
Materials. Ten electrophysiology catheters, five quadripo-
lar diagnostic catheters (Daig, St. Jude Co., Minnesota) and
five deflectable thermistor-tipped ablation catheters (EPT,
Sunnyvale, California) were used five times each and sterilized
after each use with hydrogen peroxide plasma sterilization. In
addition to the 10 catheters used in actual electrophysiology
studies, three additional ablation catheters were sterilized a
total of 20 times with aggressive manipulation of each catheter
between cycles to simulate clinical use.
Sterilization procedure. Each catheter was washed and
cleaned of debris with soap and warm tap water for 5 min,
rinsed under running tap water and dried with a towel. The
catheter was then placed in a commercially available steriliza-
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tion pouch (Baxter Inc., Inglewood, California) in preparation
for the hydrogen peroxide gas plasma sterilization procedure
(STERRAD System, Advanced Sterilization Products, Irvine
California).
Hydrogen peroxide plasma sterilization uses low tempera-
ture, low moisture and gas plasma. Gas plasma is defined as a
fourth state of matter consisting of clouds of ions, neutrons and
electrons created by the application of an electric or magnetic
field. The sterilization procedure is divided into two phases: a
diffusion phase and a plasma phase. The diffusion phase allows
the hydrogen peroxide to come into close proximity with the
items to be sterilized. The plasma phase of the cycle creates
free radicals, such as hydroperoxyl and hydroxyl radicals, that
are known to be reactive with almost all of the molecules
essential for normal metabolism of living cells.
The sterilization procedure begins by placing the object to
be sterilized in a vacuum chamber into which hydrogen
peroxide, at a minimum concentration of 6 mg/L, is injected
and vaporized. The hydrogen peroxide gas is then allowed to
diffuse throughout the sterilizer load for 50 min. Radiofre-
quency energy of 400 watts is then applied to create hydrogen
peroxide gas plasma. Hydrogen peroxide plasma is then bro-
ken apart into reactive species that collide with and kill
microorganisms. At the end of the plasma phase, the reactive
species lose their high energy and recombine to form oxygen,
water and other nontoxic byproducts. The plasma is main-
tained for a long enough period to ensure complete steriliza-
tion, with a standard plasma phase lasting 15 min. The total
sterilization procedure takes approximately 1 h.
Analysis of sterilization effects. Mechanical integrity eval-
uation consisted of examining each catheter for torque capa-
bility by confirming one-to-one torque with manipulation. The
positive and negative curve of deflectable tip ablation catheters
was also measured. Electrical integrity was evaluated by mea-
suring resistance and signal quality for each use. Visual and
microscopic inspection of each catheter was performed by
looking for gross visual defects and for changes in surface
characteristics by both light microscopy (303 and 1503 mag-
nification) and scanning electron microscopy (7503 magnifi-
cation).
Sterility testing included evaluation of the sterilization
technique against resistant bacterial and viral organisms, as
well as assessing sterility of the catheters used in this study.
Bacterial testing consisted of Sterility Assurance Level (SAL)
testing and Association of Official Analytical Chemists
(AOAC) sporicidal testing. The SAL testing was performed by
first selecting bacteria that are highly resistant to the steriliza-
tion technique and then measuring the amount of sterilization
time and/or sterilant required to sterilize a large number (106)
of the resistant organism to less than 1026. Sterilization is a
probability function, and a SAL value of 1026 means that the
probability of an organism surviving after sterilization is less
than 1026. Organism number was measured using two ac-
cepted Association for the Advancement of Medical Instru-
mentation (AAMI) standards: survivor-curve analysis and frac-
tion negative analysis. The AOAC sporicidal testing was
performed by attempting to sterilize a large number of carriers
contaminated with high numbers of both aerobic and anaero-
bic bacterial spores. The tips and connector ends of the
catheters used in this study were plated on agar plates and
incubated at 37° for 5 days to measure for growth of any
organisms.
Viral testing included evaluating the sterilization technique
against both hydrophilic (polio) and lipophilic (herpes) viruses.
Viral loads of at least 3 Log 10 were subjected to an abbrevi-
ated sterilization cycle of 30 min, and infectivity was measured.
In addition, specific testing was performed against human
immunodeficiency virus (HIV). Four petri dishes containing a
total of 6.5 Log 10 HIV-1 virus suspended in cell culture media
was sterilized for a 25-min (half normal) cycle and residual
HIV-1 activity was measured.
For the evaluation of chemical residuals immediately after
the sterilization procedure, catheters were placed in deionized
water and extraction of chemical residuals was allowed for 4 h.
The type and amount of chemical residuals in the extract were
then measured using gas chromatography.
Cost analysis. Actual costs for each catheter were obtained
and are expressed in terms of 1996 dollars. The cost for the
sterilization procedure was estimated by adding the per pro-
cedure cost of the sterilization system (by calculating the initial
cost of the sterilization system, depreciation on capital equip-
ment and the percentage of use for electrophysiology cathe-
ters) and the cost of chemicals necessary for each sterilization
cycle. Cost of the sterilization procedure is also expressed in
1996 dollars. At our institution, three quadripolar diagnostic
catheters, one decapolar catheter and one quadripolar ablation
catheter are typically used for each ablation procedure.
Statistical analysis. Change in radii for the deflectable
catheters and resistance values were analyzed using repeated
measures and analysis of variance (ANOVA).
Results
Mechanical and electrical integrity. Catheter torque capa-
bility remained one to one after 5 uses in all 10 catheters and
in the 3 additional ablation catheters sterilized 20 times. The
total change in both positive and negative tip deflection of the
ablation catheters was less than 2 mm (positive direction: 1.9 6
0.2 mm; negative direction: 1.6 6 0.3 mm). Once maximally
deflected, all catheters exhibited stable curvature retention.
Electrical integrity of all catheters was also maintained with no
significant change in resistance or loss of signal quality noted
with up to 20 sterilization cycles.
Visual inspection. One ablation catheter in the study ex-
hibited insulation fraying at the insulation–electrode interface
after the fifth use (Fig. 1). Insulation fraying was only detected
when 303 magnification or greater was used. In addition, glue
separation on the electrode surface was observed in this
catheter. No other examples of glue separation were identified
by microscopy in the other ablation catheters. No loss of
surface integrity was observed in any of the diagnostic cathe-
ters. Both light microscopy and scanning electron microscopy
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revealed no significant changes in surface characteristics asso-
ciated with the sterilization process (Fig. 1). The slight de-
crease in the degree of black residue that can be observed after
sterilization on electron microscopy is thought to be a cleans-
ing effect.
Sterility. The bacterial organism most resistant to the
sterilization technique was Bacillus stearothermophilus ATCC
7953 (Fig. 2). The organism was then used in SAL testing and
was effectively sterilized to a level of ,1026 with 30 min of
diffusion time using both survivor curve and fraction negative
analysis (Fig. 3). Both methods of analysis provided similar
values. With AOAC sporicidal testing, no failures to achieve
complete sterilization were observed. Finally, no growth was
noted from any catheter tip or connector after 5 days of
incubation.
Viral testing demonstrated no remaining infectivity with
either the lipophilic herpes or hydrophilic polio virus after a
20-min diffusion cycle of sterilization. HIV-1 was completely
inactivated with half cycle sterilization of 25 min.
Chemical residuals. The only chemical residual found im-
mediately after sterilization was hydrogen peroxide at a con-
centration of 0.22%. If the catheters were left at room air, the
rate of aeration of the residual was rapid at a few minutes. If
the catheters were left in the sterilization bags, a common
practice, a 65% aeration of hydrogen peroxide residual was
recorded in 24 h.
Cost. The average cost of an electrophysiology catheter
was $200 to $800 (average $500). The average cost of one
hydrogen peroxide sterilization cycle was approximately $10.
The reuse of each catheter five times would lead to a cost
savings of $2,000 per catheter. With three to five catheters used
for the average ablation procedure, a cost savings of $6,000 to
$10,000 could be realized for every five ablation procedures
performed.
Discussion
The results of this study suggest that hydrogen peroxide
plasma sterilization can provide a safe and cost-effective means
of reusing electrophysiology catheters. This is the first study to
include extensive testing of a catheter sterilization technique
against resistant bacterial and viral contaminants. Specific
organisms that are highly resistant to the sterilization proce-
dure were chosen for bacterial testing. Viral testing included
Figure 1. Electrophysiology catheter tip before (A and B) and after (C
and D) sterilization at 303 (top row) and 1503 (bottom row)
magnification. The slight decrease in the degree of black residue that
can be observed after sterilization on electron microscopy is thought to
be a cleansing effect. Fraying of the catheter insulation can be observed
in the upper right of the 303 photographs (arrowhead). The oval
defect in the upper left portion of the electrode is loss of surface glue
(arrow).
Figure 2. Amount of sterilization time required to achieve
organism levels of ,1026 for several common, highly resistant
bacterial spores (B. stearothermophilus, B. subtilis, B. pumilus
and C. sporogenes). The fraction of negative samples is plotted
to the right. B. stearothermophilus spores were the most
resistant of the tested spores.
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common viruses as well as testing against HIV. While testing
against hepatitis B virus was not part of this study, other
investigators have reported that hydrogen peroxide plasma
sterilization is effective against hepatitis B virus (12).
Previous studies. The significant cost of electrophysiology
catheters has led to widespread interest in the reuse and
sterilization of these devices. Dunnigan et al (9) compared the
cost of single use of electrophysiology catheters with catheter
reuse. Catheters were reused an average of eight times each.
The billing cost for a reused catheter was $30 versus $635 for
a new catheter, leading to an estimated cost savings of
$257,395 over a 5-year period. Similarly, Avitall et al. (10)
reported a significant cost savings of $129,024 over 336 abla-
tion procedures when catheters were reused an average of five
times.
The safety of reusing electrophysiology catheters after
sterilization with ethylene oxide has also been the subject of
several studies. Dunnigan et al. (9) retrospectively analyzed
catheter reuse over a 5-year period at their institution. No
complications directly attributed to catheter reuse were ob-
served and adequate sterility was maintained. In a prospective
study, Avitall et al. (10) evaluated 69 ablation catheters used in
336 ablation procedures over a 1-year period. With an average
of five uses, no major catheter failures or adverse clinical
events were observed. More recently, Aton et al. (11) randomly
examined 12 catheters with extensive electrical, chemical and
microbiological testing. While no electrical or microbiological
problems were identified, elevated concentrations of ethylene
oxide, ethylene chlorohydrin and ethylene glycol which ex-
ceeded FDA standards were detected; excessive chemical
residuals were still detected even after extended periods of
aeration (48 h). On the basis of this finding, the authors
recommended that electrophysiologic catheters should only be
used once.
Cost analysis. The potential cost savings with catheter
reuse in this study is similar to that found in the previous
studies. The average cumulative cost of an ablation procedure
is $7,000 to $10,000 (8). Material costs account for 25 to 30%
of the total expenditure, with catheters accounting for a
majority of that cost. Reuse of each diagnostic and ablation
catheter five times could potentially lead to a significant cost
savings.
Chemical residuals. Although catheter reuse can lead to
significant cost savings, the potential hazard of chemical resid-
uals has led to concern regarding the safety of this practice with
standard ethylene oxide sterilization (11). In the current study,
low concentrations of hydrogen peroxide residuals (0.22%)
were detected after the sterilization procedure. The AAMI
lists hydrogen peroxide residuals as nontoxic and negligible
(13). For comparison, hydrogen peroxide used as a topical
antiseptic is a 3% solution; despite the common use of topical
hydrogen peroxide as a disinfectant, there is no epidemiologic
evidence to suggest that hydrogen peroxide has significant
harmful effects.
Catheter integrity. The mechanical and electrical integrity
of nonlumen electrophysiology catheters was preserved after 5
uses and after as many as 20 sterilization cycles. In this study,
surface integrity was maintained in all but one catheter.
Insulation fraying at the insulation–electrode interface and
glue separation were observed in one ablation catheter after
the fifth use, but no other evidence of glue separation could be
identified in the other ablation catheters. These findings are
similar to a previous study that evaluated reuse of ablation
catheters with ethylene oxide sterilization; the investigators
observed tip electrode glue separation in 25% of ablation
catheters after an average of four uses (10). While no adverse
clinical outcomes were associated with glue separation, weak-
ening of catheter integrity could not be ruled out; the investi-
gators speculated that electrode temperatures .100° during
the ablation procedure were responsible for glue separation
(10). In our single example of glue separation, the average
ablation temperature was 50 to 60°, which suggests that glue
Figure 3. Amount of sterilization time required to achieve B.
stearothermophilus spore levels of ,1026 using both survivor
curve analysis and fraction negative analysis. The results
yielded a similar linear regression relationship.
1387JACC Vol. 32, No. 5 BATHINA ET AL.
November 1, 1998:1384–8 HYDROGEN PEROXIDE STERILIZATION OF CATHETERS
separation can occur with temperatures that are commonly
used during ablation procedures. As previously reported, ap-
plication of radiofrequency energy was associated with shallow
pitting in the tip electrode (Fig. 1) (10). We were unable to
identify any mechanical or electrical integrity or sterility prob-
lems associated with pitting.
No diagnostic catheters exhibited any problems associated
with repeated use. It may be that costly specialized multielec-
trode diagnostic catheters are most appropriate for repeated
use since glue separation and shallow pitting are probably due
to the transmission of radiofrequency energy through the
electrode surface. Hydrogen peroxide plasma sterilization may
be particularly suitable for sterilizing heat- and moisture-
sensitive materials, such as electrophysiology catheters, since a
low-temperature and low-moisture environment is used.
Limitations. First, while hydrogen peroxide plasma steril-
ization appears to be a promising technique that could be
applied to electrophysiology catheters, this study was not
designed to examine clinical end points. Larger studies that
address clinical outcomes will be necessary to evaluate the
complete safety of this technique. Second, although sterility
testing was performed against many common bacterial and
viral organisms, many less common organisms that may cause
infections were not specifically tested. Unusual organisms,
such as fungi, may be resistant to hydrogen peroxide plasma
sterilization. Finally, selected catheters from a limited number
of manufacturers were evaluated in this study. It is possible
that the effectiveness and safety of hydrogen peroxide plasma
sterilization may differ among catheters from different manu-
facturers, and that mechanical stability may also differ among
manufacturers.
Clinical implications. The practice of catheter resteriliza-
tion can potentially result in significant cost savings. The
results of this study suggest that hydrogen peroxide plasma
sterilization may provide an alternative to ethylene oxide gas
sterilization that is equal in efficacy but free of the potential
hazards of toxic chemical residuals. In particular, specialized
multielectrode diagnostic catheters may be most appropriate
for catheter reuse. However, if catheter reuse is considered,
careful inspection of all catheters, particularly at the insulation–
electrode interface, is required.
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